Assessment of HL7 FHIR Interoperability Between EHR Systems and the Survivorship Passport v2.0 Platform to Generate Treatment Summaries for Childhood Cancer Survivors in Six Clinics: Preliminary Testing Results.


Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
22 Aug 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: ppublish

Résumé

The Survivorship Passport (SurPass) for childhood cancer survivors provides a personalized treatment summary together with a care plan for long-term screening of possible late effects. HL7 FHIR connectivity of Electronic Health Record (EHR) systems with the SurPass has been proposed to reduce the burden of collecting and organizing the relevant information. We present the results of testing and validation efforts conducted across six clinics in Austria, Belgium, Germany, Italy, Lithuania, and Spain. We also discuss ways in which this experience can be used to reduce efforts for the SurPass integration in other clinics across Europe.

Identifiants

pubmed: 39176615
pii: SHTI240646
doi: 10.3233/SHTI240646
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1280-1284

Auteurs

Davide Saraceno (D)

Cineca Interuniversity Consortium, Bologna, Italy.

Catherine Chronaki (C)

HL7 Europe, Brussels, Belgium.

Giorgio Cangioli (G)

HL7 Europe, Brussels, Belgium.

Anna-Liesa Filbert (AL)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Mainz, Germany.

Monica Muraca (M)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Alessandra Berti (A)

Cineca Interuniversity Consortium, Bologna, Italy.

Rita Rielli (R)

Cineca Interuniversity Consortium, Bologna, Italy.

Nikos Thomopulos (N)

Cineca Interuniversity Consortium, Bologna, Italy.

Lisa Knoerr (L)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Mainz, Germany.

Diana Walz (D)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Mainz, Germany.

Anke Neumann (A)

IRCCS Istituto Giannina Gaslini, Genova, Italy.

Andrea Beccaria (A)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Anna Aulicino (A)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Brigitte Nicolas (B)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Giacomo Cavalca (G)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Anne Uyttebroeck (A)

University Hospitals Leuven KU, Louvain, Belgium.

Maria van Helvoirt (M)

University Hospitals Leuven KU, Louvain, Belgium.

Tom Brié (T)

University Hospitals Leuven KU, Louvain, Belgium.

Erik Vanden Meersch (E)

University Hospitals Leuven KU, Louvain, Belgium.

Ruth Ladenstein (R)

CCRI, Vienna, Austria.

Edit Bardi (E)

St.Anna Children's Hospital, Vienna, Austria.
Kepler University Clinic, Linz, Austria.

Günter Schreier (G)

AIT Austrian Institute of Technology, Graz, Austria.

Stefan Beyer (S)

AIT Austrian Institute of Technology, Graz, Austria.

Markus Müllner-Rieder (M)

AIT Austrian Institute of Technology, Graz, Austria.

María Teresa Tormo Alcañiz (MT)

Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Lucas Cervero Beltran (L)

Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Jelena Rascon (J)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Monika Kapitančukė (M)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Justas Trinkūnas (J)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Eglė Stukaitė-Ruibienė (E)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Paulius Ragauskas (P)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Audronė Ciesiūnienė (A)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Riccardo Haupt (R)

IT Center for Clinical Research, University of Luebeck, Luebeck, Germany.

Desiree Grabow (D)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH